For research use only. Not for therapeutic Use.
Vigabatrin(CAT: I004577) is an antiepileptic medication primarily used to treat refractory complex partial seizures and infantile spasms. It works by irreversibly inhibiting the enzyme gamma-aminobutyric acid transaminase (GABA-T), leading to an increase in the levels of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain. This elevated GABA concentration helps reduce neuronal excitability and seizure activity. Despite its effectiveness in controlling seizures, Vigabatrin is associated with the risk of vision loss due to retinal toxicity, and its use is typically reserved for patients who have not responded to other treatments. It remains a crucial option in the management of difficult-to-treat epilepsy.
| Catalog Number | I004577 |
| CAS Number | 68506-86-5 |
| Synonyms | (S)-4-aminohex-5-enoic acid |
| Molecular Formula | C6H11NO2 |
| Purity | ≥95% |
| Target | GABA Receptor |
| Solubility | H2O: ＞ 52 mg/mL |
| Storage | Store at -20°C |
| InChIKey | PJDFLNIOAUIZSL-UHFFFAOYSA-N |
